Alkeus Pharmaceuticals, Inc.

ACTIVE

278 Elm St Ste 229, 马萨诸塞州米德尔塞克斯县, Massachusetts, United Stateswww.alkeuspharma.comHolding1–10 employeesEstablished: 2011-01-01

Clinical Trials

2 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2011

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

40.0%

Not Applicable

20.0%

Phase 1

20.0%

Phase 3

20.0%

Trial Status Distribution

Active, not recruiting

40.0%

Completed

40.0%

Recruiting

20.0%

Clinical Trials

Trials sponsored by this organization (5)

Study of ALK-001 on the Progression of Stargardt Disease

Phase 3

Recruiting

interventional

Jun 2026230 participants

Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)

Phase 2

Active, not recruiting

interventional

Dec 2019200 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations

Alkeus Pharmaceuticals, Inc.

Overview

Trial Phase Distribution

Trial Status Distribution

Clinical Trials

Trials sponsored by this organization (5)

Study of ALK-001 on the Progression of Stargardt Disease

Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)

Phase 2/3 Study of ALK-001 in Geographic Atrophy

Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease

Phase 1 Safety Study of ALK-001 in Healthy Volunteers

Approvals

News